105 related articles for article (PubMed ID: 26812461)
1. Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.
Walker HE; Rosenberg SM; Stanton AL; Petrie KJ; Partridge AH
J Adolesc Young Adult Oncol; 2016 Mar; 5(1):16-23. PubMed ID: 26812461
[TBL] [Abstract][Full Text] [Related]
2. Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET).
Shelby RA; Dorfman CS; Bosworth HB; Keefe F; Sutton L; Owen L; Corsino L; Erkanli A; Reed SD; Arthur SS; Somers T; Barrett N; Huettel S; Gonzalez JM; Kimmick G
Contemp Clin Trials; 2019 Jan; 76():120-131. PubMed ID: 30472215
[TBL] [Abstract][Full Text] [Related]
3. Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory.
AlOmeir O; Patel N; Donyai P
Support Care Cancer; 2020 Nov; 28(11):5075-5084. PubMed ID: 32601852
[TBL] [Abstract][Full Text] [Related]
4. Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women.
Lee AY; Lyons AT; Makris V; Kamaraju S; Stolley MR; Neuner JM; Flynn KE
Support Care Cancer; 2024 Apr; 32(4):265. PubMed ID: 38565669
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer.
Rosenberg SM; Zheng Y; Gelber S; Ruddy KJ; Poorvu P; Sella T; Tamimi RM; Wassermann J; Schapira L; Borges VF; Come S; Peppercorn J; Sepucha KR; Partridge AH
Breast Cancer Res Treat; 2023 Feb; 197(3):547-558. PubMed ID: 36436128
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic, clinical, psychosocial, and healthcare-related factors associated with beliefs about adjuvant endocrine therapy among breast cancer survivors.
Sutton AL; Salgado TM; He J; Hurtado-de-Mendoza A; Sheppard VB
Support Care Cancer; 2020 Sep; 28(9):4147-4154. PubMed ID: 31897782
[TBL] [Abstract][Full Text] [Related]
7. Impact of preexisting mental illness on breast cancer endocrine therapy adherence.
Haskins CB; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA
Breast Cancer Res Treat; 2019 Feb; 174(1):197-208. PubMed ID: 30465157
[TBL] [Abstract][Full Text] [Related]
8. Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors.
Heiney SP; Truman S; Babatunde OA; Felder TM; Eberth JM; Crouch E; Wickersham KE; Adams SA
Am J Clin Oncol; 2020 Jul; 43(7):504-509. PubMed ID: 32251120
[TBL] [Abstract][Full Text] [Related]
9. Randomized Controlled Pilot Trial of a Low-Touch Remotely-Delivered Values Intervention to Promote Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors.
Arch JJ; Crespi CM; Levin ME; Genung SR; Nealis M; Mitchell JL; Bright EE; Albright K; Magidson JF; Stanton AL
Ann Behav Med; 2022 Aug; 56(8):856-871. PubMed ID: 35323853
[TBL] [Abstract][Full Text] [Related]
10. Talking About My Care: Detecting Mentions of Hormonal Therapy Adherence Behavior in an Online Breast Cancer Community.
Yin Z; Xie W; Malin BA
AMIA Annu Symp Proc; 2017; 2017():1868-1877. PubMed ID: 29854258
[TBL] [Abstract][Full Text] [Related]
11. Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors.
Caan BJ; Emond JA; Su HI; Patterson RE; Flatt SW; Gold EB; Newman VA; Rock CL; Thomson CA; Pierce JP
J Clin Oncol; 2012 May; 30(13):1492-7. PubMed ID: 22430275
[TBL] [Abstract][Full Text] [Related]
12. Identifying at risk populations amongst breast cancer survivors and their common symptoms and concerns.
Roy P; Kovalenko I; Gomez JC; Lu K; Rudge B; Wert Y; Torp L
BMC Womens Health; 2023 Jun; 23(1):302. PubMed ID: 37291544
[TBL] [Abstract][Full Text] [Related]
13. Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer.
Jacobs JM; Walsh EA; Rapoport CS; Antoni MH; Park ER; Post K; Comander A; Peppercorn J; Safren SA; Temel JS; Greer JA
J Clin Psychol Med Settings; 2021 Sep; 28(3):603-618. PubMed ID: 33219901
[TBL] [Abstract][Full Text] [Related]
14. Symptom Map of Endocrine Therapy for Breast Cancer: A Scoping Review.
Zhu Y; Cohen SM; Rosenzweig MQ; Bender CM
Cancer Nurs; 2019; 42(5):E19-E30. PubMed ID: 30138143
[TBL] [Abstract][Full Text] [Related]
15. Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer.
Anderson JN; Paladino AJ; Blue R; Dangerfield DT; Eggly S; Martin MY; Schwartzberg LS; Vidal GA; Graetz I
J Cancer Surviv; 2023 Dec; ():. PubMed ID: 38114711
[TBL] [Abstract][Full Text] [Related]
16. Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews.
Todd A; Waldron C; McGeagh L; Norris R; Bolnykh I; Stewart SJ; Slodkowska-Barabasz J; Moon Z; Cahir C; Thompson S; Harmer V; Wells M; Watson E; Sharp L;
Cancer Med; 2024 Feb; 13(3):e6937. PubMed ID: 38240343
[TBL] [Abstract][Full Text] [Related]
17. Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers.
Lee KT; Gonzalez BD; Geiss C; Fulton HJ; Charles D; Vadaparampil ST; Henry NL; Jim HSL; Hershman DL; Tworoger SS; Gwede CK
J Cancer Surviv; 2024 Mar; ():. PubMed ID: 38520598
[TBL] [Abstract][Full Text] [Related]
18. Role of life satisfaction, emotional support, and feeling of social isolation on adherence to breast cancer screening recommendations among US women.
Datta BK; Gummadi A; Coughlin SS
J Cancer Policy; 2024 Mar; 39():100467. PubMed ID: 38253239
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Survivors' Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence.
Ibrar M; Peddie N; Agnew S; Diserholt A; Fleming L
Front Psychol; 2022; 13():861198. PubMed ID: 35602711
[TBL] [Abstract][Full Text] [Related]
20. Re: "Diagnostic Delays in Breast Cancer Among Young Women: An Emphasis on Healthcare Providers" by Costa et al.
Sonola O
Clin Breast Cancer; 2024 Feb; ():. PubMed ID: 38403497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
